{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:52:40Z","timestamp":1794473560804,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.autrev.2024.103614","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T03:22:14Z","timestamp":1725074534000},"page":"103614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular disease in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis of observational studies"],"prefix":"10.1016","volume":"23","author":[{"given":"Ziyi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anji","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103614_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.berh.2012.01.005","article-title":"Undifferentiated CTD: a wide spectrum of autoimmune diseases","volume":"26","author":"Mosca","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccm.2012.01.004","article-title":"Interstitial lung disease in the connective tissue diseases","volume":"33","author":"Antin-Ozerkis","year":"2012","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.autrev.2024.103614_bb0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/09031936.00009015","article-title":"An official American Thoracic Society\/European Respiratory Society statement: research questions in COPD","volume":"45","author":"Celli","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2024.103614_bb0020","author":"N.L.o. Medicine"},{"key":"10.1016\/j.autrev.2024.103614_bb0025","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s10067-023-06656-y","article-title":"Cardiovascular issues in rheumatic diseases","volume":"42","author":"Zimba","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0030","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0220-2021","article-title":"Recent advances in the management of pulmonary hypertension with interstitial lung disease","volume":"31","author":"Waxman","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2024.103614_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacbts.2021.11.003","article-title":"Research opportunities in autonomic neural mechanisms of cardiopulmonary regulation: a report from the national heart, lung, and blood institute and the national institutes of health office of the director workshop","volume":"7","author":"Mehra","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.autrev.2024.103614_bb0040","article-title":"Cardiovascular involvement in connective tissue disease: the role of interstitial lung disease","volume":"10","author":"Wang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103614_bb0045","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2024.103614_bb0050","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/rheumatology\/kez076","article-title":"Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan","volume":"58","author":"Weng","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103614_bb0055","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/1756-185X.14128","article-title":"Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy","volume":"24","author":"Bai","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103614_bb0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.002","article-title":"Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study","volume":"123","author":"Ji","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2024.103614_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10067-018-4353-2","article-title":"Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease","volume":"38","author":"Cobo-Ib\u00e1\u00f1ez","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0070","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00296-017-3781-7","article-title":"Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis","volume":"37","author":"Kim","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2024.103614_bb0075","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103614_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","article-title":"Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor \u03b1 agents, a retrospective cohort study","volume":"17","author":"Curtis","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103614_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","article-title":"Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study","volume":"57","author":"Reiseter","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103614_bb0090","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/rheumatology\/keaa547","article-title":"Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 131","key":"10.1016\/j.autrev.2024.103614_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.55563\/clinexprheumatol\/9ivp9g","article-title":"Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA","volume":"39","author":"Sankar","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semarthrit.2019.11.005","article-title":"Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort","volume":"50","author":"Noviani","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103614_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3899\/jrheum.170307","article-title":"All-cause healthcare costs and mortality in patients with systemic sclerosis with lung involvement","volume":"45","author":"Fischer","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0110","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s12325-020-01330-0","article-title":"Healthcare resource utilization among patients in England with systemic sclerosis-associated interstitial lung disease: a retrospective database analysis","volume":"37","author":"Gayle","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.autrev.2024.103614_bb0115","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/art.38623","article-title":"Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease","volume":"66","author":"Volkmann","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103614_bb0120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2024.103614_bb0125","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2018.11.063","article-title":"Association of Cardiovascular Disease with Respiratory Disease","volume":"73","author":"Carter","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2024.103614_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.rmed.2019.04.009","article-title":"Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care","volume":"152","author":"Frank","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2024.103614_bb0135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3111\/13696998.2012.680553","article-title":"Burden of illness in idiopathic pulmonary fibrosis","volume":"15","author":"Collard","year":"2012","journal-title":"J Med Econ"},{"key":"10.1016\/j.autrev.2024.103614_bb0140","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.rmed.2014.03.015","article-title":"The burden of idiopathic pulmonary fibrosis: an unmet public health need","volume":"108","author":"Lee","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2024.103614_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684699","article-title":"Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations","volume":"12","author":"Shao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103614_bb0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fphys.2017.00777","article-title":"The processes and mechanisms of cardiac and pulmonary fibrosis","volume":"8","author":"Murtha","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2024.103614_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.533","article-title":"Left ventricular dysfunction in an idiopathic pulmonary fibrosis patient on nintedanib","volume":"8","author":"Imai","year":"2020","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.autrev.2024.103614_bb0160","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.autrev.2005.11.002","article-title":"Connective tissue diseases and cardiac rhythm disorders: an overview","volume":"5","author":"Lazzerini","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103614_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13075-018-1735-4","article-title":"Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China","volume":"20","author":"Hu","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103614_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.784601","article-title":"Phenotypic presentations of heart failure among patients with chronic inflammatory diseases","volume":"9","author":"Underberg","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.autrev.2024.103614_bb0175","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/acr.25016","article-title":"Association of systemic sclerosis with incident clinically evident heart failure","volume":"75","author":"Lin","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2024.103614_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2024.103614_bb0185","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2024.103614_bb0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5582\/irdr.2016.01023","article-title":"Cardiac manifestations of idiopathic pulmonary fibrosis","volume":"5","author":"Agrawal","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.autrev.2024.103614_bb0195","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2024.103614_bb0200","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S2213-2600(22)00097-2","article-title":"Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis","volume":"10","author":"Hoeper","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.autrev.2024.103614_bb0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12931-022-02144-0","article-title":"Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease","volume":"23","author":"Jo","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2024.103614_bb0210","first-page":"Cd014936","article-title":"Smoking cessation for secondary prevention of cardiovascular disease","volume":"8","author":"Wu","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2024.103614_bb0215","article-title":"Effects of tobacco smoking on cardiovascular disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103614_bb0220","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2024.103614_bb0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.autrev.2024.103614_bb0230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000195334","article-title":"Relationship between lung inflammation or fibrosis and frequency dependence of compliance in interstitial pulmonary diseases","volume":"52","author":"Perez Neria","year":"1987","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2024.103614_bb0235","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.chest.2021.04.037","article-title":"Incidence and prognostic significance of hypoxemia in fibrotic interstitial lung disease: an international cohort study","volume":"160","author":"Khor","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2024.103614_bb0240","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0059-2021","article-title":"Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome","volume":"30","author":"Gierhardt","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.autrev.2024.103614_bb0245","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00395-014-0432-y","article-title":"Pulmonary vascular tone is dependent on the central modulation of sympathetic nerve activity following chronic intermittent hypoxia","volume":"109","author":"Shirai","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.autrev.2024.103614_bb0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0034-1371527","article-title":"Biomarkers in connective tissue disease-associated interstitial lung disease","volume":"35","author":"Bonella","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2024.103614_bb0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s40001-023-01384-0","article-title":"Clinical significance of interleukin-6, total bilirubin, CD3+CD4+T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study","volume":"28","author":"Ma","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.autrev.2024.103614_bb0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2022.02.015","article-title":"Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases","volume":"530","author":"Zhang","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2024.103614_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31138\/mjr.33.1.1","article-title":"B cell depletion treatment in resistant systemic sclerosis interstitial lung disease","volume":"33","author":"Bounia","year":"2022","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0270","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/mr\/road068","article-title":"Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: a subgroup analysis of a global, randomised, controlled phase 3 trial","volume":"34","author":"Kuwana","year":"2024","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2024.103614_bb0275","first-page":"470","article-title":"Interstitial lung disease in rheumatic diseases - new therapeutic approaches","volume":"145","author":"Jakubczyc","year":"2020","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.autrev.2024.103614_bb0280","article-title":"Efficacy and safety of nintedanib in patients with connective tissue disease-interstitial lung disease (CTD-ILD): a real-world single center experience","volume":"13","author":"Boutel","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2024.103614_bb0285","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","article-title":"Validity of diagnostic coding within the general practice research database: a systematic review","volume":"60","author":"Khan","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.autrev.2024.103614_bb0290","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10067-010-1494-3","article-title":"Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis","volume":"29","author":"Dimitroulas","year":"2010","journal-title":"Clin Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:41:14Z","timestamp":1728481274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1568997224001058"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103614","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis of observational studies","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103614"}}